Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases
Glioblastoma (GBM) is the most common and lethal primary malignant brain tumor, and due to its unique features, its management is certainly one of the most challenging ones among all cancers. N6-isopentenyladenosine (IPA) and its analog N6-benzyladenosine (N6-BA) are modified nucleosides endowed wit...
Saved in:
Main Authors: | Maria Chiara Proto (Author), Donatella Fiore (Author), Chiara Piscopo (Author), Chiara Laezza (Author), Maurizio Bifulco (Author), Patrizia Gazzerro (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019
by: Maurizio Bifulco, et al.
Published: (2021) -
Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids
by: Donatella Fiore, et al.
Published: (2018) -
Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
by: Thomas RP, et al.
Published: (2012) -
Pre-treatment or Post-treatment of Human Glioma Cells With BIX01294, the Inhibitor of Histone Methyltransferase G9a, Sensitizes Cells to Temozolomide
by: Iwona Anna Ciechomska, et al.
Published: (2018) -
Role of DNA Methyltransferases in the Epigenome
by: Jeltsch, Albert
Published: (2020)